Capella NURS FPX 4035 Assessment 3

Improvement Plan In-Service Presentation

Hello! I am _________. I appreciate your presence here today. In this session, I will emphasize a concern affecting patient security: Medication Errors (MEs) in hospital settings. The objective of this presentation is to provide nurses with applied methods to recognize the underlying reasons of MEs, apply evidence-based measures to diminish their rate, and respond when they happen. We aim to strengthen communication among healthcare staff, strengthen compliance with safe prescribing and administration standards, and promote a culture of safety through accuracy and teamwork in nursing practice.

Part 1: Agenda and Outcomes

Agenda

The proposed training session will reinforce the knowledge that nurses have about MEs and the methods to prevent them in stressful clinical settings. In the session, participants will use real-life scenarios of MEs and discuss how issues like staff shortage, poor communication, ambiguous drug policies, and outdated systems led to these events. Current approaches to improve medication security will also be presented to nurses, such as Computerized Provider Order Entry (CPOE), Barcode Scanning of Medication Administration (BCMA), Clinical Decision Support Systems (CDSS), and structured communication strategies, like SBAR (Situation, Background, Assessment, Recommendation).

The interactive part of the program, including scenario-based group discussions and practical simulations, will enable the participants to exercise safe drug administration and error-reduction methods within a friendly learning environment. Updated safety policies from the quality improvement initiative will be reviewed. This highlights each nurse’s responsibility in promoting a culture of safety and accountability. A section of the session will be dedicated to open discussion, questions, and feedback. By the end, participants should feel confident in their ability to detect, prevent, and manage MEs through teamwork and consistent use of current practices.

Goals

1. Recognize the impact of MEs on patient safety and healthcare quality, and build practical skills for preventing such incidents.

The session will start by highlighting the impact of MEs on patient health, daily clinical operations, and organizational efficiency. Such errors result in treatment delays, harmful drug reactions, and extended hospital admissions. This raises healthcare expenditures and reduces patient confidence (Stolic et al., 2022). Nurses will explore real-life examples where incorrect doses, wrong administration methods and communication gaps caused patient harm. Practical solutions will be introduced, such as BCMA, CPOE, and structured handoff methods like SBAR, to support early recognition and prevention of MEs. Participants will refine their skills in confirming medication accuracy, detecting possible risks, and maintaining a culture of responsibility. This promotes a safer care setting.

1. Identify system-based and human features that impact MEs and explore interventions to prevent such incidents in healthcare settings.

Capella NURS FPX 4035 Assessment 3

This segment of the training will help participants recognize organizational and individual factors that contribute to MEs, such as limited staffing, outdated drug administration methods, lack of adequate training on safety technologies, inconsistent recordkeeping, and failures in communication. Nurses will explore how these challenges raise the risk of incorrect dosages, omitted medications, and harmful drug reactions. This threatens patient safety and reduces the quality of care. Evidence-based strategies, including BCMA, medication reconciliation, and structured handoff approaches, will be reviewed (Albeshri et al., 2024). Attendees will develop the ability to anticipate medication safety concerns in their practice environment and work together on organizational improvements that encourage precision and a culture of safety.

1. Explain the use of structured communication and safety tools to prevent MEs and enhance patient outcomes.

Participants will take part in dynamic, scenario-based learning activities and simulated practice sessions to apply tools such as SBAR, BCMA, and CPOE. These methods improve precision in verifying medications. This enables early recognition of mistakes and supports prompt, well-coordinated responses in high-risk situations (Albeshri et al., 2024). Nurses will be guided on adjusting their communication techniques when confirming medication orders, reconciling drug lists, and collaborating with multidisciplinary teams. They will implement standardized safety measures with assurance in real-world practice settings. These practical exercises will strengthen knowledge and critical thinking, promoting lasting skill growth needed to minimize MEs and ensure patient protection.

Outcomes

At the end of this session, applicants will be proficient in:

• Recognize how MEs affect patient safety, clinical outcomes, and healthcare costs.
• Understand the human and organizational factors that contribute to MEs.
• Apply evidence-based medication safety practices, including the use of BCMA, CPOE, and CDSS, in simulated clinical scenarios.
• Use standardized communication tools, such as SBAR, to enhance clarity and accuracy in medication-related handoffs.
• Follow updated medication safety protocols in daily practice.
• Collaborate with interdisciplinary teams to prevent, identify, and respond to potential MEs.

Part 2: Safety Improvement Plan

MEs continue to be a key risk to security in modern care organizations, in critical care settings like Intensive Care Units (ICU). MEs affect roughly 1 in every 10 persons, with close to 8% of these incidents resulting in fatal outcomes. Patients in ICUs experience frequent medication adjustments and are prescribed larger doses, which heightens the risk of mistakes. Research indicates that ICUs report an average of 1.7 MEs per patient each day, with deadly mistakes occurring more frequently in these settings (Coelho et al., 2024). They cause harmful drug reactions, prolonged stays in the hospital, and increased expenses.

It causes patient mistrust and, in worst cases, unnecessary deaths. The contributing factors are shortages in staff, communication breakdowns, inadequate training in safe medication practices, and inconsistent documentation. These problems are further complicated by more systematic ones, such as the utilization of obsolete digital systems, the absence of unified standards, and low levels of organizational dedication to medication safety programs (Naseralallah et al., 2022). These are the issues that require an organization-wide approach that would improve precision, accountability, and adherence to evidence-based standards.

Proposed Plan Overview

The offered patient safety plan aims at reducing the MEs incidence through raising the nursing expertise, collaboration between healthcare professions, and standardizing medication administration. The necessary aspects involve training nurses to be attentive in confirming medication orders and utilizing BCMA, CPOE, and CDSS systems to detect possible risks. The strategy focuses on systematic instruments like SBAR to communicate handoff and real-time digital records to enhance collaboration and protect the patients (Albeshri et al., 2024). Appropriate in-service training and simulation-based learning encourage a culture of precision, attention, and shared responsibility. Such actions allow every team member to assist in the decrease of MEs and the improvement of care quality.

Why This Matters to the Organization

MEs must be managed to protect patients, maintain clinical excellence, and achieve the legal and ethical responsibilities of healthcare organizations. These mistakes represent a major source of preventable injury, hospital readmissions, and rising costs. National bodies like the Centers for Disease Control and Prevention (CDC) and the Agency for Healthcare Research and Quality (AHRQ) play a serious role in improving medical security across U.S. health systems. They fund research, establish evidence-based recommendations, and encourage large-scale initiatives aimed at reducing errors (AHRQ, n.d.).

Healthcare organizations that neglect medication safety face potential lawsuits, loss of public trust, and declines in care standards. This improvement agenda supports national patient safety goals by promoting accountability, adopting uniform medication administration practices, and integrating advanced safety technologies. Leadership’s dedication to ethical practice is reflected in challenging MEs, protecting patient outcomes, and building a strong healthcare system (Chen et al., 2022).

Part 3: Audience’s Role and Importance

Nurses are essential in carrying out safety initiatives intended to reduce MEs. They are expected to apply organized communication methods such as SBAR, along with technologies like BCMA, and electronic documentation during shift transitions and team-based care. They confirm medication orders, resolve unclear prescriptions, address possible discrepancies, and escalate safety concerns without hesitation. Nurses can lead improvement efforts by recognizing high-risk situations, working in partnership with prescribers and pharmacists, and guiding patients and families on proper medication use and compliance (Alhur et al., 2024). Their vigilance, accuracy, and teamwork provide a strong protection against MEs, creating a safer environment of care for every patient.

Why Nurses’ Role Is Critical to the Plan’s Success

The involvement of nurses is vital because they are the main connection in the continuum of care of a patient. Their role is to oversee every stage of the medication process, enabling nurses to identify risks and unsafe practices early on and take swift actions to prevent harm. The studies indicate that empowering nurses to scrutinize orders, address discrepancies, employ safety technologies, and collaborate with pharmacists and prescribing providers lowers the frequency of MEs (Alhur et al., 2024). Nurses are in responsible of continuous supervision, comprehensive judgment, and interdisciplinary collaboration in any clinical environment. Organized medication safety programs cannot be successful without the active participation of the people.

How Nurses Will Benefit from the Implementation of This Role

The active involvement of nurses in a medication safety improvement program allows them to develop their professional skills and job satisfaction while protecting patients. They build confidence in recognizing early warning signs of MEs, enhance teamwork across disciplines, and cultivate a culture centered on precision and mutual respect. This initiative supports evidence-based nursing practice, reducing clinical and emotional consequences of MEs (Rodziewicz et al., 2024). Nurses are empowered to promote safer care settings and reinforce their vital role as supporters for patient health. They contribute to long-lasting enhancements in medication management and quality of care within their organization.

Part 4: New Process and Skills Practice

The ICU will implement a structured communication and escalation strategy to manage MEs. This method includes standardized error reporting tools, providing electronic and paper-based records to ensure accuracy and transparency. Immediate safety briefings will be held during peak activity periods and after any identified errors to enhance team collaboration and situational awareness. A medication safety checklist will assist nurses in recognizing early warning signs of potential prescribing, dispensing, and administration issues. Specialized training programs will be combined to prepare staff with the knowledge and skills needed to prevent and respond to MEs confidently (Alhur et al., 2024). The plan establishes an internal escalation pathway, allowing nurses to avoid conventional hierarchies and promptly alert pharmacy teams and leadership if a risk is not addressed on time.

Practical Activity 

During this session, staff will engage in a scenario-based simulation modeled after an actual MEs in the ICU. The case will highlight a patient receiving a double dose of analgesic medicine due to incomplete documentation, miscommunication among providers, and missing verification steps. Although warning signs such as unclear prescriptions and inconsistencies on medication labels were present, the error was not caught because of fragmented information flow and a lack of coordinated safety checks. This simulation will serve as the basis for a role-playing activity (Shahzeydi et al., 2025).

Participants will be divided into small teams, with each group taking on the role of the primary nurse responsible for preparing and administering medications. They will utilize a “Medication Safety Checklist” to detect potential risks, confirm medication orders, and complete both electronic and paper-based error reports. Teams will practice prevention measures, including read-back confirmation, BCMA, and timely consultation with pharmacists when discrepancies are identified. After the exercise, groups will review their communication strategies, teamwork, and safety interventions, receiving constructive feedback to improve their skills. This activity aims to enhance clinical awareness, standardize safe medication procedures, and strengthen interdisciplinary teamwork to prevent MEs.

Collaborative Q/A Activity

The Q&A segment is designed to ensure nursing staff engage with the updated medication safety program in the ICU. A common concern is, “What if reporting a medication error leads to criticism from colleagues?” In these situations, staff are encouraged to follow the structured escalation pathway. The protocol promotes a supportive, non-punitive environment that prioritizes staff well-being and ensures all safety concerns are addressed without fear of retaliation. Another frequent question is, “How can we determine if a potential error is serious or minor?”

Nurses are guided to identify risk factors and warning signs using standardized tools such as the Medication Safety Checklist. Some ask, “Will documenting errors and completing checklists slow down our workflow?” While it seems time-consuming initially, these procedures are designed to integrate into daily practice and prevent incidents that would require far more time and resources to correct. A recurring inquiry is, “Will support continue after this training?” This program is part of a constant medication safety initiative that includes refresher trainings, scenario-based simulations, open feedback channels, and access to clinical resources to ensure staff remain confident, vigilant, and capable of preventing MEs in high-risk situations.

Part 5: Soliciting Feedback

The MEs prevention initiative and in-service session will measure success by collecting input from all participants through confidential written surveys and a brief open discussion after the session. The surveys will evaluate the clarity of the training materials, the applicability of the CPOE and BCMA simulation exercises, and suggestions for enhancing medication safety procedures (Albeshri et al., 2024). In the open discussion, the nurses will be offered the opportunity to express preliminary impressions, challenges faced during the exercises, and innovative proposals on how to reinforce safe medication practices.

This two-way feedback approach is both motivating and fosters open feedback and a culture of shared responsibility. The feedback will be critically read and sorted into major themes. Common suggestions include streamlining the electronic medication ordering procedure, enhancing the double-check system, and conducting refresher sessions regularly. The inclusion of frontline staff input ensures that the program remains viable, efficient, and aligned to minimize MEs in clinical practice.

Conclusion

MEs prevention plan is an evidence-based method of safeguarding patients. This initiative will help solve human and system-based error contributors by combining the use of advanced technologies, including BCMA, CPOE, and CDSS, and applying structured communication tools, such as SBAR. Feedback and refinement continuously guarantee that the plan will be practical and in line with changing clinical requirements. This program enhances nursing practice, minimizes avoidable harm, and supports the organization’s focus on standard of healthcare practices.

References

Agency of Healthcare Research and Quality. (n.d.). The institute for safe medication practices. https://psnet.ahrq.gov/issue/institute-safe-medication-practices 

Albeshri, S. M., Alharbi, R. A., Alhawsa, H. zakria , Bilal, A. M., Alowaydhi, B. Y., Alzahrani, O. M., Fallata, S. M., Almaliki, S. O., Alfadly, W. N., & Albarakati, A. obaidullah. (2024). The role of nursing in reducing medical errors: Best practices and systemic solutions. Journal of Ecohumanism, 3(7), 4613–4622. https://doi.org/10.62754/joe.v3i7.4574

Alhur, A., Alhur, A. A., Al-Rowais, D., Asiri, S., Muslim, H., Alotaibi, D., Al-Rowais, B., Alotaibi, F., Al-Hussayein, S., Alamri, A., Faya, B., & Rashoud, W. (2024). Enhancing patient safety through effective interprofessional communication: A focus on medication error prevention. Cureus, 16(4). https://doi.org/10.7759/cureus.57991

Chen, J., Ghardallou, W., Comite, U., Ahmad, N., Ryu, H. B., & Han, H. (2022). Managing hospital employees’ burnout through transformational leadership: The role of resilience, role clarity, and intrinsic motivation. International Journal of Environmental Research and Public Health, 19(17), 10941. https://doi.org/10.3390/ijerph191710941

Coelho, F., Furtado, L., Mendonça, N., Soares, H., Duarte, H., Costeira, C., Santos, C., & Pereira Sousa, J. (2024). Predisposing factors to medication errors by nurses and prevention strategies: A scoping review of recent literature. Nursing Reports, 14(3), 1553–1569. https://doi.org/10.3390/nursrep14030117

Capella NURS FPX 4035 Assessment 3

Naseralallah, L., Stewart, D., Azfar Ali, R., & Paudyal, V. (2022). An umbrella review of systematic reviews on contributory factors to medication errors in healthcare settings. Expert Opinion on Drug Safety, 21(11), 1379–1399. https://doi.org/10.1080/14740338.2022.2147921

Rodziewicz, T. L., Houseman, B., Vaqar, S., & Hipskind, J. E. (2024). Medical error reduction and prevention. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK499956/

Shahzeydi, Farzi, Rezazadeh, Tarrahi, M. J., Farzi, & Hosseini, S. A. (2025). Comparison of the effects of medication error encouragement training and low-fidelity simulation on the medication safety competence and knowledge of nursing students: A quasi-experimental study. Nurse Education Today, 149, 106676. https://doi.org/10.1016/j.nedt.2025.106676

Stolic, S., Ng, L., Southern, J., & Sheridan, G. (2022). Medication errors by nursing students on clinical practice: An integrative review. Nurse Education Today, 112, 105325. https://doi.org/10.1016/j.nedt.2022.105325